Effectiveness of Acupuncture for Asthma

Not Applicable

Completed

• Conditions: Asthma
• Interventions: Device: Disposable stainless steel acupuncture (0.2mmx4mm)

• Registration Number: NCT00917215
• Lead Sponsor: Korea Institute of Oriental Medicine

Brief Summary

What is the trend of changes in asthmatic patients' daily peak expiratory flow (PEF) variability, pulmonary function, and quality of life (QOL) with acupuncture treatment on specific acupoints (CV22 and bilateral LU5, ST40, BL13, EXB1) compared with minimal acupuncture treatment (sham control group) on non-acupoints, and no acupuncture treatment (waiting list control group)?

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09
• Primary Completion: 2009-04
• Study Completion: 2009-04
• Study First Submitted: 2009-06-09
• Study First Submitted QC: 2009-06-09
• Study First Posted: 2009-06-10
• Status Verified: 2009-07
• Last Update Submitted: 2009-07-29
• Last Update Posted: 2009-07-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

• aged 19-70 years
• at least 12% improvement in forced expiratory volume in one second (FEV1)after the administration of short acting beta2 agonist.
• at least one typical asthmatic symptom
• using more than one routine anti-asthmatic medicine

Exclusion Criteria

• acupuncture for asthma within 12 months of the study
• emergency department visit within one month of the study
• hospitalization for asthma within three months of the study
• severe upper respiratory tract infections within six weeks of the study
• systemic infections, cancers, autoimmune disorders, cardiac failures, myofacial infarcts,angina pectoris, renal failures or hepato-biliary diseases
• smoke more than ten cigarettes per day

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Active acupuncture	Disposable stainless steel acupuncture (0.2mmx4mm)	-
Sham acupuncture	Disposable stainless steel acupuncture (0.2mmx4mm)	-

Primary Outcome Measures

Name	Time	Method
Change of weekly average of peak expiratory flow (PEF)values in the morning at home	From 1 week of run-in period to the 4th week of treatment

Secondary Outcome Measures

Name	Time	Method
Forced expiratory volume in 1 second (FEV1) Baseline Dyspnea Index (BDI) Transition Dyspnea Index (TDI) Quality of Life Questionnaire for Adult Korean Asthmatics (QLQAKA)	Baseline and 2 weeks, 4 weeks, 6 weeks after Baseline (BDI for baseline only, TDI for 2, 4, and 6 weeks after baseline)

Trial Locations

Locations (1)

Division of Allergy & Respiratory System, Department of Oriental Internal Medicine, Kyunghee medical center; 🇰🇷 Seoul, Korea, Republic of